Shaw R W, Ndukwe G, Imoedemhe D, Burford G, Chan R
Fertil Steril. 1986 Jul;46(1):135-7. doi: 10.1016/s0015-0282(16)49472-0.
Pulsatile subcutaneous administration of LH-RH (14.4 micrograms/pulse/90 minutes) during the midfollicular phase (days 7 to 11) of the cycle induced significant increases in circulating LH, FSH, and E2 in all eight women treated. When CC (150 mg/day on days 2 to 6) was administered prior to the LH-RH, multiple follicular development occurred, five to seven mature follicles (greater than 16 mm) being found on day 12 of the cycle. The administration of pulsatile LH-RH in this manner may prove to be an additional regimen for use in IVF programs.
在月经周期的卵泡中期(第7至11天),对8名接受治疗的女性进行促黄体生成激素释放激素(LH-RH)的皮下脉冲给药(14.4微克/脉冲/90分钟),可使所有女性的循环促黄体生成素(LH)、促卵泡生成素(FSH)和雌二醇(E2)显著增加。当在LH-RH给药前给予克罗米芬(CC,第2至6天每天150毫克)时,出现了多个卵泡发育,在周期的第12天发现了5至7个成熟卵泡(大于16毫米)。以这种方式进行脉冲式LH-RH给药可能被证明是体外受精(IVF)方案中可采用的另一种治疗方案。